China Resources Pharmaceutical Announces AGM Results and Board Changes

China Resources Pharmaceutical Group Ltd. ( (HK:3320) ) has provided an announcement.

China Resources Pharmaceutical Group Ltd. announced the results of its Annual General Meeting held on May 23, 2025, where all proposed resolutions were passed. Key resolutions included the re-election and election of several directors, authorization for the board to fix directors’ remuneration, reappointment of KPMG as auditors, and granting of mandates to buy back and issue new shares. These decisions are expected to strengthen the company’s governance and operational capabilities, potentially enhancing its market position and shareholder value.

The most recent analyst rating on (HK:3320) stock is a Buy with a HK$7.50 price target. To see the full list of analyst forecasts on China Resources Pharmaceutical Group Ltd. stock, see the HK:3320 Stock Forecast page.

More about China Resources Pharmaceutical Group Ltd.

China Resources Pharmaceutical Group Ltd. operates in the pharmaceutical industry, focusing on the production and distribution of pharmaceutical products. The company is known for its comprehensive range of healthcare products and services, catering to both domestic and international markets.

Average Trading Volume: 13,781,897

Technical Sentiment Signal: Sell

Current Market Cap: HK$31.79B

See more data about 3320 stock on TipRanks’ Stock Analysis page.